Article info
PDFViral hepatitis
Peginterferon α-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response
- Correspondence to:
Dr S M Kamal
Department of Gastroenterology and Liver Disease, Ain Shams Faculty of Medicine, 22 Al Ahram St, Roxy, Heliopolis, Cairo, Egypt; sanaa.kamal{at}link.net
Citation
Peginterferon α-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response
Publication history
- Received September 24, 2004
- Accepted November 26, 2004
- First published May 11, 2005.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Gut